Exercise program aims to boost strength in young cancer patients
NCT ID NCT07647471
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
The BEPPO study is testing whether a structured exercise program can improve physical and mental health in 346 children and teens (ages 3-18) undergoing cancer treatment across 13 German centers. Participants are randomly assigned to either a 6-month exercise program (3-5 sessions per week) plus counseling, or standard care. The main goal is to improve leg strength, with secondary aims including endurance, balance, fatigue, and quality of life. The study hopes to provide evidence to make exercise a routine part of pediatric oncology care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- structured exercise program (strength, endurance, coordination, flexibility, balance) plus family-centered exercise counseling
- What this could lead to
- If it works, this could make exercise a standard part of pediatric cancer care, helping kids feel stronger, less tired, and better overall during treatment.
- What could go wrong
- This is a relatively early-stage study (not yet recruiting) and exercise may be hard to stick with during intensive treatment. Results may not apply to all children or cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité-Universitätsmedizin Berlin, Department of Pediatric Oncology/Hematology
Berlin, Germany
-
Children's Hospital Amsterdamer Straße, ; Clinic for Children and Youth Medicine; Department for pediatric hematology/oncology
Cologne, Germany
-
DIAKONEO Klinik Hallerwiese-Cnopfsche Kinderklinik Nürnberg, Department of Pediatric Hematology and Oncology
Nuremberg, Germany
-
Klinikum der Landeshauptstadt Stuttgart, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie
Stuttgart, Germany
-
Pädiatrische Hämatologie und Onkologie, Zelltherapie Zentrum für Kinder- und Jugendmedizin Eine Kooperation der München Klinik und des TUM Klinikums
München, Germany
-
University Hospital Cologne, Department of Pediatric Oncology and Hematology, Children's Hospital
Cologne, Germany
-
University Hospital Essen, Department of Pediatric Hematology/Oncology, Center for Child and Adolescent Medicine, Clinic for Pediatrics III
Essen, Germany
-
University Medical Center Ulm, Department of Pediatrics and Adolescent Medicine
Ulm, Germany
-
University of Bonn Medical Center, Department of Pediatric Hematology/Oncology,
Bonn, Germany
-
Universitätsklinikum Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hubertus Wald Tumor Center, University Cancer Center Hamburg
Hamburg, Germany
-
Universitätsklinikum Jena, Klinik für Kinder- und Jugendmedizin
Jena, Germany
-
Universitätsmedizin Frankfurt, Department of Pediatrics, Pediatric Oncology and Haematology
Frankfurt, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Department of Pediatric Hematology/Oncology
Mainz, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.